91 related articles for article (PubMed ID: 19483282)
1. Relation of promoter methylation of mdr-1 gene and histone acetylation status with multidrug resistance in MCF-7/Adr cells.
Huang C; Cao P; Xie Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):369-74. PubMed ID: 19483282
[TBL] [Abstract][Full Text] [Related]
2. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
Reed K; Hembruff SL; Sprowl JA; Parissenti AM
Pharmacogenomics J; 2010 Dec; 10(6):489-504. PubMed ID: 20125118
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.
Baker EK; Johnstone RW; Zalcberg JR; El-Osta A
Oncogene; 2005 Dec; 24(54):8061-75. PubMed ID: 16091741
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
7. Role for Class I histone deacetylases in multidrug resistance.
Xu Y; Jiang Z; Yin P; Li Q; Liu J
Exp Cell Res; 2012 Feb; 318(3):177-86. PubMed ID: 22154511
[TBL] [Abstract][Full Text] [Related]
8. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
[TBL] [Abstract][Full Text] [Related]
9. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles.
Gao Y; Chen L; Zhang Z; Chen Y; Li Y
Biomaterials; 2011 Feb; 32(6):1738-47. PubMed ID: 21112086
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation and histone acetylation patterns in cultured bovine fibroblasts for nuclear transfer.
Giraldo AM; Lynn JW; Purpera MN; Godke RA; Bondioli KR
Mol Reprod Dev; 2007 Dec; 74(12):1514-24. PubMed ID: 17440941
[TBL] [Abstract][Full Text] [Related]
13. Arabidopsis DNA methyltransferase AtDNMT2 associates with histone deacetylase AtHD2s activity.
Song Y; Wu K; Dhaubhadel S; An L; Tian L
Biochem Biophys Res Commun; 2010 May; 396(2):187-92. PubMed ID: 20331964
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
15. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells.
Chekhun VF; Kulik GI; Yurchenko OV; Tryndyak VP; Todor IN; Luniv LS; Tregubova NA; Pryzimirska TV; Montgomery B; Rusetskaya NV; Pogribny IP
Cancer Lett; 2006 Jan; 231(1):87-93. PubMed ID: 16356834
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells.
Kim KJ; Moon SM; Kim SA; Kang KW; Yoon JH; Ahn SG
Oncogene; 2013 Jul; 32(28):3339-49. PubMed ID: 22907429
[TBL] [Abstract][Full Text] [Related]
17. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
19. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
